Observational Prospective Analysis of Biological Characteristics of Mesothelioma Patients
NCT02300883 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2022-09-09
Summary
This is an observational prospective analysis of biological characteristics of malignant mesothelioma (MM) patients. Frozen and paraffin-embedded tumor specimens and pleural effusion of patients will be collected and than will be analyzed with the following analyses:
1Purification of Tumour Associated Macrophages (TAM) and tumour cells from pleural effusions.
2.Mass spectrometry analysis of TAMs and tumor cells 3.Co focal microscopy analysis of macrophages, tumour cells and specimens derived from patients.
Conditions
- Malignant Mesothelioma
Sponsors & Collaborators
-
Armando Santoro, MD
lead OTHER
Principal Investigators
-
armando Santoro, MD · Istituto Clinico Humanitas
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-04-30
- Primary Completion
- 2017-12-31
- Completion
- 2018-01-31
Countries
- Italy
Study Locations
More Related Trials
-
Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy
NCT00897481 ·Status: UNKNOWN
-
Serum Biomarkers in Diagnosis of Mesothelioma
NCT02029105 ·Status: COMPLETED
-
Identification and Characterization of Predictive Factors of Onset of Bone Metastases in Cancer Patients
NCT03895216 ·Status: COMPLETED
-
Detection of Plasmatic Cell-free BRAF and NRAS Mutations : a New Tool for Monitoring Patients with Metastatic Malignant Melanoma Treated with Targeted Therapies or Immunotherapy ( MALT )
NCT03493230 ·Status: COMPLETED ·Phase: NA
-
Mesothelioma Early Detection by VOCs
NCT04106973 ·Status: TERMINATED
-
Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma
NCT00004153 ·Status: COMPLETED ·Phase: NA
-
Genetic Susceptibility in MAlignant Pleural Mesothelioma: Clinical Implication of GermliNE VariaTionS
NCT06886672 ·Status: RECRUITING
-
Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers
NCT06608511 ·Status: RECRUITING
-
S9431: Studying Genes and Immune Response in Tumor Samples From Patients With Locally Advanced or Metastatic Melanoma
NCT00898183 ·Status: COMPLETED
-
Metabolic Phenotypes in Melanoma
NCT05570227 ·Status: RECRUITING ·Phase: NA
-
Morphological, Genetic and Tumour Microenvironment Characterisation in Uveal Melanoma
NCT05889481 ·Status: UNKNOWN
-
Assessment of Circulating Tumor Cells and microRNAs in Patients With Metastatic Non-cutaneous Melanoma
NCT06863870 ·Status: ACTIVE_NOT_RECRUITING
-
Detection of Circulating Osteosarcoma Tumor Cells in the Blood of Patients Using the Polymerase Chain Reaction
NCT00588510 ·Status: COMPLETED
-
A Prospective Study of Plasma Genotyping as a Noninvasive Biomarker for Genotype-directed Cancer Care
NCT02279004 ·Status: ACTIVE_NOT_RECRUITING
-
Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment
NCT02105168 ·Status: UNKNOWN ·Phase: NA
-
Collecting Blood and Tissue Samples From Family Members of Patients With Pancreatic Diseases, Pancreatic Cancer, and Melanoma
NCT00835133 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical Utility Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine Tumors
NCT02948946 ·Status: COMPLETED
-
Melanoma Molecular Profiling Analysis
NCT00889980 ·Status: COMPLETED
-
Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma
NCT00685750 ·Status: TERMINATED ·Phase: NA
-
Pan-tumor MRD Study
NCT06605404 ·Status: RECRUITING
-
Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome
NCT04431024 ·Status: RECRUITING
-
IP3R Modulation by Cancer Genes in Mesothelioma
NCT03558932 ·Status: UNKNOWN
-
Biomarkers of Angiogenesis and Disease in Patients With Unresectable Malignant Mesothelioma Treated on Clinical Trial CALGB-30107
NCT00898547 ·Status: TERMINATED
-
Diagnostic Study to Predict the Risk of Developing Metastatic Cancer in Patients With Stage I or Stage II Melanoma
NCT00049010 ·Status: COMPLETED ·Phase: NA
-
Role of Circulating Tumor DNA (ctDNA) From LIquid Biopsy in Early Stage NSCLC Resected Lung Tumor Investigation
NCT03553550 ·Status: TERMINATED